Teicoplanin Dosage Recommendations
For patients with normal renal function, administer a loading dose of 6-12 mg/kg every 12 hours for three doses, followed by maintenance dosing of 6-12 mg/kg once daily, with the higher end (12 mg/kg) reserved for severe infections such as endocarditis and septic arthritis. 1, 2
Loading Dose Strategy (Critical for All Patients)
The loading dose remains unchanged regardless of renal function and must always be administered at full dose. 1, 2
- Standard infections: 6 mg/kg every 12 hours for three doses 2
- Severe infections (endocarditis, septic arthritis, osteomyelitis, complicated bacteremia): 12 mg/kg every 12 hours for three doses 2, 3
- The rationale is that loading doses depend on volume of distribution, not clearance, and are essential to rapidly achieve therapeutic levels 1
- Failure to provide adequate loading doses is the most common prescribing error and leads to treatment failure 2
Maintenance Dosing Based on Renal Function
After completing the loading regimen, adjust maintenance dosing intervals according to GFR:
Normal to Mild Renal Impairment
Moderate Renal Impairment
Severe Renal Impairment
Dialysis Patients
- Hemodialysis: Loading dose 12 mg/kg, then 6 mg/kg on days 2 and 3, followed by 6 mg/kg once weekly 1, 2, 3
- CAVH(D)-CVVH(D): Follow GFR 10-50 mL/min dosing (every 48 hours) 1, 2
- CAPD peritonitis (IV route): Follow GFR <10 mL/min dosing (every 72 hours) 1, 2
Dose Selection: 6 mg/kg vs 12 mg/kg
Use 12 mg/kg for severe infections requiring trough concentrations ≥20 mg/L: 1, 2
- Staphylococcal endocarditis 1, 4
- Septic arthritis 1, 4
- Osteomyelitis 2, 3
- MRSA infections with high MIC values 3
- Complicated bacteremia 3
Use 6 mg/kg for standard infections requiring trough concentrations ≥10 mg/L: 1, 2
- Skin and soft tissue infections
- Uncomplicated bacteremia
- Pneumonia (non-severe)
Target Trough Concentrations
- Standard infections: Trough ≥10 mg/L 1, 2
- Severe infections: Trough ≥20 mg/L 1, 2, 3
- Research suggests that achieving initial trough concentrations ≥15 μg/mL significantly improves clinical success rates (75.0% vs 50.0%, p=0.008) 1
Therapeutic Drug Monitoring Indications
Routine monitoring is not required for most patients, but is strongly indicated in specific high-risk situations: 1, 2
- S. aureus endocarditis or septic arthritis 1, 2
- Major burns 1, 2
- Intravenous drug users 1, 2
- Rapidly changing renal function 1, 2
- Immunocompromised patients 1, 2
- MRSA infections with high MIC values 2
Critical Pitfalls to Avoid
Inadequate loading doses: This is the most common error and leads to subtherapeutic levels regardless of renal function 1, 2
Failure to extend dosing intervals in renal impairment: Not adjusting intervals leads to drug accumulation and potential toxicity 1, 2
Underdosing severe infections: Standard 400 mg daily dosing frequently results in subtherapeutic levels; higher doses (600 mg or 12 mg/kg) are needed for severe infections 5, 4
Overlooking therapeutic drug monitoring in high-risk patients: This can lead to treatment failure in severe infections where target troughs of ≥20 mg/L are essential 1, 2